Evidence map›Paper›PMID 35443942›Full record

ArticleBMJ open2022

Reliability and validity of the Chinese version of the Family Resilience Questionnaire (FaRE Questionnaire) in patients with breast cancer: a cross-sectional study.

Mengmeng Li, Rui Ma, Shanfeng Zhang, Shanshan Wang, Jiawei Jiao, Lamei Liu, Panpan Wang, Zhenxiang Zhang, Peng Wang, Xiaoyan Li

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. The influence of family resilience and benefit finding on the financial toxicity of primary caregivers of patients with advanced cancer: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Mengmeng Li *School of Nursing and Health, Zhengzhou University, Zhengzhou, Henan, China.
Rui Ma *College of Psychological Education (Based school), Zhengzhou University, Zhengzhou, Henan, China.
Shanfeng Zhang *Experimental Center for Basic Medicine, Zhengzhou University, Zhengzhou, Henan, China.
Shanshan WangSchool of Nursing and Health, Zhengzhou University, Zhengzhou, Henan, China.
Jiawei JiaoSchool of Nursing and Health, Zhengzhou University, Zhengzhou, Henan, China.
Lamei LiuSchool of Nursing and Health, Zhengzhou University, Zhengzhou, Henan, China.
Panpan WangSchool of Nursing and Health, Zhengzhou University, Zhengzhou, Henan, China.
Zhenxiang ZhangSchool of Nursing and Health, Zhengzhou University, Zhengzhou, Henan, China.
Peng WangSchool of Nursing and Health, Zhengzhou University, Zhengzhou, Henan, China upliz@zzu.edu.cn 1475919311@qq.com.ORCID 0000-0003-1925-1363
Xiaoyan LiNursing department, Zhengzhou Central Hospital Affiliated To Zhengzhou University, Zhengzhou, China upliz@zzu.edu.cn 1475919311@qq.com.
Zhengzhou University · CNZhengzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to assess the reliability and validity of the Chinese version of the Family Resilience (FaRE) Questionnaire among patients with breast cancer in China.

designIt was a cross-sectional study, which involved translation, back-translation, cultural adjustment and psychometric testing of a 24-item FaRE Questionnaire.

settingThree tertiary hospitals in Zhengzhou, China: respectively are the First Affiliated Hospital of Zhengzhou University, Second Hospital Affiliated to Zhengzhou University and Henan Provincial People's hospital.

participantsA total of 559 patients with breast cancer volunteered to participate in the study PRIMARY OUTCOME MEASURES: Data analysis was performed using the IBM SPSS software V.21.0 and AMOS software V.21.0. Cronbach's α coefficient was used to examine the internal consistency. The test-retest reliability was calculated using the intraclass correlation coefficient on 30 participants. The content validity index was calculated based on the values obtained from six expert opinions. Construct validity test was performed using factor analysis including exploratory factor analysis and confirmatory factor analysis.

resultsFor the Chinese version of FaRE Questionnaire, the Cronbach's α coefficient of the total questionnaire was 0.909, and Cronbach's α coefficients of four factors were 0.902, 0.932, 0.905 and 0.963, respectively. The test-retest reliability index of the total questionnaire was 0.905. The Scale-Content Validity Index was 0.97, and Item-Content Validity Index ranged from 0.83 to 1.00. The questionnaire included 24 items, exploratory factor analysis extracted four factors with loading >0.4, which could explain 72.146% of the total variance. Confirmatory factor analysis showed the Chinese version of FaRE Questionnaire had an excellent four-factor model consistent with the original questionnaire.

conclusionThe Chinese version of FaRE Questionnaire has acceptable reliability and validity among patients with breast cancer in China. It can effectively assess family resilience and provide basis for personalised family resilience interventions for patients with breast cancer.

Indexed as

Breast NeoplasmsResilience, PsychologicalChinaCross-Sectional StudiesFamily HealthFemaleHumansPsychometricsReproducibility of ResultsSurveys and Questionnaireshealth policyoncologypsychiatry

Identifiers

PMID35443942
PMCPMC9021805
OpenAlexW4224274061

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.